NXGL
NexGelBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
Current thesis
Standalone 2025 revenue grew 31.5% to $11.4 million with gross margin improving to about 39.5%, and the Celularity transaction could materially expand scale if financed and closed [#10-K-2026-03-31] [#8-K-2026-03-10].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Additional capital raises or equity-linked financing could be materially dilutive at the current share price.
Momentum
89
Value
36
Sentiment
49
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.65 · Bull $1.10 · Bear $0.25
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $6.00
Why
Momentum89 · Δ7d -
Value36 · Δ7d -0.0
Sentiment49 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
89
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
49
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 88.8 / Value 36.3 / Sentiment 48.6
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$6.81M
Beta
0.59
Shares Out
8.14M
P/E (TTM) · Derived
-1.7
P/S (TTM)
1.24
P/FCF (TTM) · Derived
-2.52
Rev YoY
-0.2%
EPS YoY
+22.3%
Gross Margin
+38.3%
Op Margin
-25.5%
Net Debt
-$756K
Current Ratio
1.69
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology